Intellectual Capital is now recognized as one of the most significant assets of the world’s largest companies.
WEED, Inc.’s IP strategy is to grow value by building a large catalog of brands, patents, trademarks, copyrights and licenses through in-house research and development and the acquisition of companies with complimentary IP holdings.
Brands are generally recognized as a crucial asset for creating value. One of the most critical factors in a company’s success is the differentiation power of its brand. For customers, a brand must immediately convey a point of difference. A brand must be credible, desirable and most importantly, recognizable. In the burgeoning international cannabis market, there is no name more recognizable than WEED, Inc. and it’s stock symbol BUDZ.
WEED, Inc. is now creating a wide variety of brands, patents, trademarks, copyrights and licenses through its subsidiaries and affiliates. WEED, Inc.’s medical cannabis IP goal is to research, identify, collect, patent, and archive a collection of highly active medicinal strains. Through its subsidiaries, WEED, Inc. will continue to expand the scope of its intellectual capital portfolio with the express purpose of acquiring and controlling the IP/Branding of existing patents, trademarks, copyrights, and licenses.
WEED, Inc. is now conducting a five-year Cannabis Genomic Study to complete the genetic blueprint of the cannabis plant genus. The defining of strain-specific cannabis DNA sequencing, pathogens, and metabolics is expected to be an IP bonanza and WEED, Inc. has positioned itself to lead the competition during the exploration of this new frontier.
Be the first to receive the latest Industry and WEED INC. News & Updates.
Weed Australia Ltd.
WEED Israel Cannabis Ltd.
The Hemp Institute of Arizona
The Cannabis Institute of Australia